全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Close Margins in Oral Cancers: Implication of Close Margin Status in Recurrence and Survival of pT1N0 and pT2N0 Oral Cancers

DOI: 10.1155/2014/545372

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction. Among all prognostic factors, “margin status” is the only factor under clinician’s control. Current guidelines describe histopathologic margin of >5?mm as “clear margin” and 1–5?mm as “close margin.” Ambiguous description of positive margin in the published data resulted in comparison of microscopically “involved margin” and “close margin” together with “clear margin” in many publications. Authors attempted to compare the outcome of close and clear margins of stage I and stage II squamous cell carcinoma of oral cavity to investigate the efficacy of description of margin status. Patients and Methods. Historical cohorts of patients treated between January 2010 and December 2011 at tertiary cancer hospital were investigated and filtered for stage I and stage II primary squamous cell carcinomas of oral cavity. Patients with margin status of tumor at margin or within 1mm from cut margin were excluded and analyzed in multivariate logistic regression model for locoregional recurrences and Cox regression for overall survival. Results. A total of 104 patients fulfilled the abovementioned criteria, of whom 36 were “clear margin” and 68 were “close margin” with median period of follow-up of 39 months. There was no significant difference in locoregional recurrence (P value: 0.0.810) and survival (P value: 0.0.851) among “close margin” and “clear margin” patients. 1. Introduction Globally lip and oral cancers together comprise of 9.7% of all the cancers [1]. Incidence of oral cancer is much higher in developing countries than developed countries. They comprise one-third of all cancers in southeast Asia [2]; the higher incidence is attributed to more popular chewable forms of tobacco in this region [3]. About 90% of oral cavity tumors are squamous cell carcinomas [4]. Surgery is primary treatment modality and best choice in oral cancers owing to anatomical considerations of complex bone and soft tissues in this area [5]; moreover morbidity associated with primary radiotherapy on quality of life and persistent xerostomia is considerable [6]. Prognostic risk factors of oral cancer include tumor staging and grading, marginal status, lymph vascular invasion, perineural spread, and perinodal spread of regional disease, of which marginal status is the only factor to a variable extent under clinician’s control [7]. Although surgeon always aims at a resection with clear margin, close margins are inevitable; complexity of oral anatomy explains the fact that positive margins are most frequent in oral cancer resection in comparison to the cancers of upper

References

[1]  A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011.
[2]  J. Farlay, F. Bray, P. Pisani, et al., GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0, IARC Cancer Base no. 5, IARC Press, Lyon, France, 2004.
[3]  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 89, World Health Organization, 2007.
[4]  J. Watkinson and R. Gilbert, “Stell & Maran's textbook of head and neck surgery and oncology,” in Lip and Oral Cavity Cancer, p. 549, CRC Press, 2012.
[5]  J. P. Shah and Z. Gil, “Current concepts in management of oral cancer—surgery,” Oral Oncology, vol. 45, no. 4-5, pp. 394–401, 2009.
[6]  A. P. Jellema, B. J. Slotman, P. Doornaert, C. R. Leemans, and J. A. Langendijk, “Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 69, no. 3, pp. 751–760, 2007.
[7]  J. P. Shah, R. A. Cendon, H. W. Farr, and E. W. Strong, “Carcinoma of the oral cavity. Factors affecting treatment failure at the primary site and neck,” The American Journal of Surgery, vol. 132, no. 4, pp. 504–507, 1976.
[8]  A. S. Jones, Z. Bin Hanafi, V. Nadapalan, N. J. Roland, A. Kinsella, and T. R. Helliwell, “Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery,” British Journal of Cancer, vol. 74, no. 1, pp. 128–132, 1996.
[9]  J. A. Woolgar and A. Triantafyllou, “A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens,” Oral Oncology, vol. 41, no. 10, pp. 1034–1043, 2005.
[10]  J. R. Jacobs, K. Ahmad, R. Casiano et al., “Implications of positive surgical margins,” The Laryngoscope, vol. 103, no. 1, pp. 64–68, 1993.
[11]  J. G. Lee, “Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: a study of surgical margins,” Transactions of the American Academy of Ophthalmology and Otolaryngology, vol. 78, no. 1, pp. 49–53, 1974.
[12]  J. D. Meier, D. A. Oliver, and M. A. Varvares, “Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society member survey,” Head & Neck, vol. 27, no. 11, pp. 952–958, 2005.
[13]  T. Helliwell and J. A. Woolgar, Standards and Minimum Datasets for Reporting cancers. Dataset for Histopathologic Reports on Head and Neck Carcinomas and Salivary Neoplasms, Royal College of Pathologists, London, UK, 2nd edition, 2005.
[14]  K. G. Looser, J. P. Shah, and E. W. Strong, “The significance of “positive” margins in surgically resected epidermoid carcinomas,” Head & Neck Surgery, vol. 1, no. 2, pp. 107–111, 1978.
[15]  T. R. Loree and E. W. Strong, “Significance of positive margins in oral cavity squamous carcinoma,” The American Journal of Surgery, vol. 160, no. 4, pp. 410–414, 1990.
[16]  J. J. Pindborg and S. M. Sirsat, “Oral submucous fibrosis,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 22, no. 6, pp. 764–779, 1966.
[17]  P. Chaturvedi, S. S. Vaishampayan, S. Nair et al., “Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease,” Head & Neck, vol. 35, no. 10, pp. 1404–1409, 2013.
[18]  G. Anneroth, J. Batsakis, and M. Luna, “Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas,” Scandinavian Journal of Dental Research, vol. 95, no. 3, pp. 229–249, 1987.
[19]  R. W. Nason, A. Binahmed, K. A. Pathak, A. A. Abdoh, and G. K. B. Sándor, “What is the adequate margin of surgical resection in oral cancer?” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 107, no. 5, pp. 625–629, 2009.
[20]  C. Barrya, R. Shawa, J. Woolgarb, S. Rogersa, D. Lowea, and J. Browna, “OP081: evidence to support: a 3?mm margin as oncologically safe in early oral SCC,” Oral Oncology, vol. 49, supplement 1, S37 pages, 2013.
[21]  J. McMahon, C. J. O'Brien, I. Pathak, et al., “Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer,” British Journal of Oral and Maxillofacial Surgery, vol. 41, no. 4, pp. 224–231, 2003.
[22]  J. G. Batsakis, “Surgical excision margins: A pathologist's perspective,” Advances in Anatomic Pathology, vol. 6, no. 3, pp. 140–148, 1999.
[23]  R. E. Johnson, J. D. Sigman, G. F. Funk, R. A. Robinson, and H. T. Hoffman, “Quantification of surgical margin shrinkage in the oral cavity,” Head and Neck, vol. 19, no. 4, pp. 281–286, 1997.
[24]  R. C. Mistry, S. S. Qureshi, and C. Kumaran, “Post-resection mucosal margin shrinkage in oral cancer: quantification and significance,” Journal of Surgical Oncology, vol. 91, no. 2, pp. 131–133, 2005.
[25]  D. González Ballester, I. Rubio Correa, C. Hernández Vila, et al., “OP082: effect of the tissue shrinkage phenomenon on surgical margins of resection in patients undergoing cancer oral and oropharynx,” Oral Oncology, vol. 49, p. S37, 2013.
[26]  M. Alicandri-Ciufelli, M. Bonali, A. Piccinini et al., “Surgical margins in head and neck squamous cell carcinoma: What is “close”?” European Archives of Oto-Rhino-Laryngology, vol. 270, no. 10, pp. 2603–2609, 2013.
[27]  J. D. Meier, D. A. Oliver, and M. A. Varvares, “Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society member survey,” Head and Neck, vol. 27, no. 11, pp. 952–958, 2005.
[28]  J. S. Cooper, K. Fu, J. Marks, and S. Silverman, “Late effects of radiation therapy in the head and neck region,” International Journal of Radiation Oncology, Biology, Physics, vol. 31, no. 5, pp. 1141–1164, 1995.
[29]  D. P. Slaughter, H. W. Southwick, and W. Smejkal, “‘Field cancerization’ in oral stratified squamous epithelium. Clinical implications of multicentric origin,” Cancer, vol. 6, no. 5, pp. 963–968, 1953.
[30]  L. S. Wong, J. McMahon, J. Devine et al., “Influence of close resection margins on local recurrence and disease-specific survival in oral and oropharyngeal carcinoma,” British Journal of Oral and Maxillofacial Surgery, vol. 50, no. 2, pp. 102–108, 2012.
[31]  S. Ch'ng, S. Corbett-Burns, N. Stanton, et al., “Close margin alone does not warrant postoperative adjuvant radiotherapy in oral squamous cell carcinoma,” Cancer, vol. 119, no. 13, pp. 2427–2437, 2013.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133